These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9572538)

  • 1. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily.
    Mundorf TK; Cate EA; Sine CS; Otero DW; Stewart JA; Stewart WC
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):129-35. PubMed ID: 9572538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.
    Stewart WC; Day DG; Sharpe ED; Dubiner HB; Holmes KT; Stewart JA
    Am J Ophthalmol; 1999 Dec; 128(6):692-6. PubMed ID: 10612504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
    Stewart WC; Leland TM; Cate EA; Stewart JA
    J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma.
    DuBiner HB; Hill R; Kaufman H; Keates EU; Zimmerman TJ; Mandell AI; Mundorf TK; Bahr RL; Schwartz LW; Towey AW; Hurvitz LM; Starita RJ; Sassani JW; Ropo A; Gunn R; Stewart WC
    Am J Ophthalmol; 1996 May; 121(5):522-8. PubMed ID: 8610795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension.
    Mundorf TK; Ogawa T; Naka H; Novack GD; Crockett RS;
    Clin Ther; 2004 Apr; 26(4):541-51. PubMed ID: 15189751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol hemihydrate: a new formulation of timolol for the treatment of glaucoma.
    Stewart WC
    J Ocul Pharmacol Ther; 1996; 12(2):225-37. PubMed ID: 8773937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study.
    Schenker HI; Silver LH
    Am J Ophthalmol; 2000 Aug; 130(2):145-50. PubMed ID: 11004287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension.
    Shibuya T; Kashiwagi K; Tsukahara S
    Ophthalmologica; 2003; 217(1):31-8. PubMed ID: 12566870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%.
    Stewart WC; Sharpe ED; Stewart JA; Hott CE
    Curr Eye Res; 2002 May; 24(5):387-91. PubMed ID: 12434307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study.
    Kumar H; Sudan R; Sethi HS; Sony P
    Indian J Ophthalmol; 2002 Mar; 50(1):21-3. PubMed ID: 12090082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.
    Konstas AG; Stewart WC; Topouzis F; Tersis I; Holmes KT; Stangos NT
    Am J Ophthalmol; 2001 Jun; 131(6):729-33. PubMed ID: 11384568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
    Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
    Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
    Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.